• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Picard Medical, Inc. (PMI)
	Q3-CY2026	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014
Balance Sheet Date		2026-Jun-30	2026-Mar-31	2025-Dec-31	2025-Sep-30	2025-Jun-30
Fiscal Period		Q2-FY2026	Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025
Total Revenue		2,954,000$	1,150,000$	1,009,000$	1,187,000$	2,131,000$	620,000$	836,000$	881,000$	694,000$
QoQ%		156.87%	13.97%	(15.00%)	(44.30%)	243.71%	(25.84%)	(5.11%)	26.95%
YoY%		38.62%	85.48%	20.69%	34.73%	207.06%
Cost Of Revenue		2,338,000$	875,000$	598,000$	1,317,000$	2,258,000$	978,000$	700,000$	1,554,000$	1,076,000$
Gross Profit		616,000$	275,000$	411,000$	(130,000$)	(127,000$)	(358,000$)	136,000$	(673,000$)	(382,000$)
Gross Margin		20.85%	23.91%	40.73%	(10.95%)	(5.96%)	(57.74%)	16.27%	(76.39%)	(55.04%)
Operating Expenses		5,245,000$	4,786,000$	3,414,000$	3,357,000$	3,394,000$	2,888,000$	3,708,000$	3,771,000$	3,442,000$
Operating Income		(4,629,000$)	(4,511,000$)	(3,003,000$)	(3,487,000$)	(3,521,000$)	(3,246,000$)	(3,572,000$)	(4,444,000$)	(3,824,000$)
Operating Margin		(156.70%)	(392.26%)	(297.62%)	(293.77%)	(165.23%)	(523.55%)	(427.27%)	(504.43%)	(551.01%)
Interest Income		0$	0$	0$	0$	0$	0$	0$	0$
Interest Expenses		89,000$	5,000$	7,000$	2,404,000$	2,427,000$	555,000$	1,431,000$	1,382,000$	172,000$
Income Before Tax		(5,653,000$)	(7,616,000$)	(4,287,000$)	(10,426,000$)	(6,724,000$)	(5,530,000$)	(8,853,000$)	(6,206,000$)	(4,057,000$)
Tax Expenses		7,000$		4,000$	0$		31,000$
Net Income		(5,660,000$)	(7,616,000$)	(4,291,000$)	(10,426,000$)	(6,724,000$)	(5,561,000$)	(8,838,000$)	(6,206,000$)	(4,057,000$)
Profit Margin		(191.61%)	(662.26%)	(425.27%)	(878.35%)	(315.53%)	(896.94%)	(1,057.18%)	(704.43%)	(584.58%)
TTM		(444.33%)	(530.53%)	(545.83%)	(660.85%)	(611.66%)	(813.66%)
Earnings to Minority						796,000$	780,000$	671,000$	683,000$	664,000$
Earnings to Common Shareholders		(5,660,000$)	(7,616,000$)	(4,291,000$)	(10,426,000$)	(7,520,000$)	(6,341,000$)	(9,509,000$)	(6,889,000$)	(4,721,000$)
QoQ%		25.68%	(77.49%)	58.84%	(38.64%)	(18.59%)	33.32%	(38.03%)	(45.92%)
YoY%		24.73%	(20.11%)	54.87%	(51.34%)	(59.29%)
Earnings Per Share, Basic		(3.05$)	(0.10$)	(0.05$)	(0.19$)	(42.39$)	(0.80$)		(0.87$)
Earnings Per Share, Diluted
Unlevered FCF Per Share, Basic		(0.73$)	(0.05$)	(0.05$)	(0.12$)		(0.28$)		(0.33$)
Unlevered FCF Per Share, Diluted
Average Shares, Basic		1,855,813	74,437,715	82,339,619	54,452,140	177,389	7,963,188		7,943,585
Average Shares, Diluted
EBIT		(5,564,000$)	(7,611,000$)	(4,280,000$)	(8,022,000$)	(4,297,000$)	(4,975,000$)	(7,422,000$)	(4,824,000$)	(3,885,000$)
EBITDA		(5,519,000$)	(7,565,000$)	(4,240,000$)	(8,022,000$)	(4,257,000$)	(4,933,000$)	(7,380,000$)	(4,824,000$)	(3,885,000$)

Copy Table ✓